Publications of M. Zweckstetter
All genres
Journal Article (285)
281.
Journal Article
17 (22), pp. 6558 - 6572 (1998)
Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): Implications for IGF and IGF-I receptor interactions. EMBO Journal 282.
Journal Article
5, pp. 682 - 686 (1998)
Structure of interleukin 16 resembles a PDZ domain with an occluded peptide binding site. Nature Structural and Molecular Biology 283.
Journal Article
133 (1), pp. 134 - 147 (1998)
An adiabatic multiple spin-echo pulse sequence: removal of systematic errors due to pulse imperfections and off-resonance effects. Journal of Magnetic Resonance 284.
Journal Article
238 (2), pp. 333 - 340 (1996)
Conversion of the Kunitz-type module of collagen VI into a highly active trypsin inhibitor by site-directed mutagenesis. FEBS Journal 285.
Journal Article
4 (2), pp. 195 - 209 (1996)
Structure and multiple conformations of the Kunitz-type domain from human type VI collagen alpha3(VI) chain in solution. Structure Conference Paper (7)
286.
Conference Paper
92 (Suppl), P1.1-006, (2019)
Structure and pro-toxic mechanism of the human Hsp90/PPIase/Tau complex. 71st Annual Meeting of the American-Academy-of-Neurology (AAN), Philadelphia, PA, May 04, 2019 - May 10, 2019. Neurology 287.
Conference Paper
116 (Suppl_1), p. 303A - 303A (2019)
Improved physical models enable the investigation of molecular recognition in intrinsically disordered proteins at atomistic rsolution. 63rd Annual Meeting of the Biophysical-Society, Baltimore, MD, March 02, 2019 - March 06, 2019. Biophysical Journal 288.
Conference Paper
110 (Suppl 1), 3 Ed., p. 358A - 358A (2016)
Structural ensembles of intrinsically disordered proteins depend strongly on force field: A comparison to experiment. 60th Annual Meeting of the Biophysical-Society, Los Angeles, CA, February 27, 2016 - March 02, 2016. Biophysical Journal 289.
Conference Paper
110 (Suppl 1), 3 Ed., p. 2a - 2a (2016)
Intrinsically disordered proteins in neurodegeneration. 60th Annual Meeting of the Biophysical-Society, Los Angeles, CA, February 27, 2016 - March 02, 2016. Biophysical Journal 290.
Conference Paper
26 (Supplement 2), p. S21 - S21 (2011)
Causal therapy of Parkinson's disease with anle138b, a novel protein aggregation inhibitor. 15th International Congress of Parkinsons Disease and Movement Disorders, Toronto, CANADA, 2011. Movement Disorders 291.
Conference Paper
36 (Suppl. 1), p. 20 - 20 (2006)
H-1, N-15, and C-13 resonance assignment of the C2A domain of rabphilin3A. Journal of Biomolecular NMR 292.
Conference Paper
88 (1), p. 396A - 396A (2005)
3D structure, ligand binding, autoinhibition, aggregation, and cellular distribution of wild-type, mutant, and labeled alpha-synuclein. Biophysical Journal Meeting Abstract (1)
293.
Meeting Abstract
279 (Suppl. 1), P20-86, p. 433 - 433. 22nd IUBMB Congress/37th FEBS Congress, Seville/Spain, September 04, 2012 - September 09, 2012. (2012)
Functional dynamics in the voltage-dependent anion channel. In FEBS Journal, Patent (1)
294.
Patent
Mutant alpha-synuclein with increased toxicity. WO/2010/015714 (2010)
Preprint (1)
295.
Preprint
A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological features. medRxiv (2025)